Samuraciclib improved progression-free survival in HR+ advanced breast cancer patients without TP53 mutations or liver ...

The U.S. Food and Drug Administration has approved AbbVie's drug to treat adults with a type of lung cancer who have received ...

Ariel Lopez-Chavez, MD, medical oncologist, director of precision medicine and developmental therapeutics at Allegheny Health Network Cancer Institute, discusses comprehensive genomic profiling and ...

Scientists have discovered how iron in lysosomes can induce ferroptosis, offering a new route to target treatment-resistant ...

Some 50,000 Australians will die from cancer this year, despite big breakthroughs in treatments. What makes cancer so very ...

The bispecific T-cell engager tarlatamab demonstrated favorable antitumor activity in a small cohort with small cell lung ...

A liver biopsy confirmed a PAX-8 and CD10 positive carcinoma, consistent with metastatic renal cell carcinoma. Following neoadjuvant therapy, the patient underwent a left radical nephrectomy, partial ...

Tumor staging was reconfirmed according to the 8th Edition of the American Joint Committee on Cancer (AJCC) TNM Classification for Lung ... 100% (small sample size). ORR in pre - treated patients was ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

A new targeted drug treatment for small cell lung cancer, understanding how obesity drives endometrial cancer, and predicting early-stage melanoma spread are among the research topics being presented ...

The absence of these NAM immune cells leads to an exaggerated inflammatory response against the COVID-19 virus, cell death, and increased viral spread ... small fraction (less than 5%) of lung ...

Figure 1: Treatment with Bria-OTS monotherapy resulted in 100% resolution of tumor in the lung of the metastatic breast cancer (MBC) patient following 2 months of therapy and confirmed at 4 months ...